查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1635878

2025-2033 年按类型、设备类型（实验室设备、护理点设备）、最终用户（实验室测试、护理点测试）和地区分類的性传染病诊断市场报告

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type (Laboratory Devices, Point of Care Devices), End User (Laboratory Testing, Point of Care Testing), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球性传染病（ IMARC Group ）诊断市场规模达1,090亿美元。性病患病率的上升、大众对早期诊断的认识不断提高以及家用性病检测试剂盒的推出是推动市场的一些关键因素。

性传染病 (STD) 诊断是指为识别和确认 STD 的存在而进行的检查、测试和拭子培养。它包括血液、体液样本和尿液检测，以检测某些 STD 的抗体或抗原的存在。广泛用于检测和筛检各种性传染病和感染，如生殖器疱疹、披衣菌、淋病、梅毒、阴蝨、滴虫病、爱滋病、细菌性阴道炎、疥疮、软下疳等。性病诊断有助于早期发现和准确治疗，预防不孕症，保护未出生的孩子免受感染，并最大限度地减少疾病传播。这些诊断方法还有助于减少长期风险的机会，增强信心，并为医生提供有关疾病及其原因的宝贵见解。

性传染病 (STD) 诊断市场趋势：

由于无保护性交和药物滥用导致的性传染病（STD）盛行率不断上升是推动市场成长的关键因素之一。性传染病诊断广泛用于检测各种引起性传染病的病原体，如细菌、病毒和寄生虫，具有高精度和可靠性，可帮助医疗保健提供者确定合适的治疗方法，防止疾病从母亲传播给婴儿，并改善患者的临床结果。除此之外，大众对早期发现和诊断性传播疾病的认识不断提高，这可以预防长期併发症，如不孕症、先天性残疾、癌症、失明、骨骼畸形、脑损伤和智力低下，正在发挥作用。此外，政府采取各种措施来提高人们对性健康和性病检测的认识，并透过教育活动、研讨会和社群媒体广告消除与之相关的社会耻辱，这也推动了市场的成长。此外，经济高效、安全、准确、方便、提供更快结果并维护隐私的家用性病检测套件的推出对市场成长产生了积极影响。此外，最近开发的基于人工智慧（AI）的行动应用程式可以透过分析个人隐私部位的数位影像来诊断性传播疾病，从而改善性传染病筛检的机会，维护机密性并保护个人资料，有利于市场成长。其他因素，包括医疗保健行业的显着增长、在电子商务平台上轻鬆获得性病诊断试剂盒以及增加对新型诊断技术研发（R＆D）的投资，预计将推动市场成长。

本报告回答的关键问题：

  • 迄今为止，全球性传染病 (STD) 诊断市场的表现如何，未来几年将如何表现？
  • 全球性传染病 (STD) 诊断市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球性传染病 (STD) 诊断市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的性传染病 (STD) 诊断市场？
  • 依类型划分市场是怎么样的？
  • 性传染病 (STD) 诊断市场中哪种类型最具吸引力？
  • 根据设备类型分類的市场是怎么样的？
  • 性传染病 (STD) 诊断市场中最具吸引力的设备类型是什么？
  • 基于最终用户的市场区隔是什么？
  • 性传染病 (STD) 诊断市场中哪一个是最具吸引力的最终用户？
  • 全球性传染病（STD）诊断市场的竞争结构如何？
  • 全球性传染病 (STD) 诊断市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球性传染病 (STD) 诊断市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 衣原体检测
    • 市场趋势
    • 市场预测
  • 梅毒检测
    • 市场趋势
    • 市场预测
  • 淋病检测
    • 市场趋势
    • 市场预测
  • 单纯疱疹病毒检测
    • 市场趋势
    • 市场预测
  • 人类乳突病毒检测
    • 市场趋势
    • 市场预测
  • 人类免疫缺乏病毒检测
    • 市场趋势
    • 市场预测
  • 软下疳测试
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按设备类型

  • 实验室设备
    • 市场趋势
    • 关键环节
      • 热循环仪 - PCR
      • 侧向层析阅读器
      • 流式细胞仪
      • 吸光度酶标仪 - 酵素连结免疫吸附测定 (ELISA)
      • 其他的
    • 市场预测
  • 护理点 (PoC) 设备
    • 市场趋势
    • 关键环节
      • 手机晶片（微流体+ICT）
      • 便携式/桌上型/快速诊断套件
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 实验室测试
    • 市场趋势
    • 市场预测
  • 护理点测试
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • BioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Cepheid (Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • Qiagen NV
    • Quidel Corporation
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112025A6956

The global sexually transmitted disease (STD) diagnostics market size reached USD 109.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 164.9 Billion by 2033, exhibiting a growth rate (CAGR) of 4.47% during 2025-2033. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:

The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) - based mobile applications that can diagnose STDs by analyzing digital images of an individual's private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

Type Insights:

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Others

Device Type Insights:

  • Laboratory Devices
  • Thermal Cycler - PCR
  • Lateral Flow Readers
  • Flow Cytometers
  • Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
  • Point of Care (PoC) Devices
  • Phone Chips (Microfluidics + ICT)
  • Portable/Bench Top/Rapid Diagnostic Kits

End User Insights:

  • Laboratory Testing
  • Point of Care (PoC) Testing

Regional Insights:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
  • What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on the device type?
  • Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
  • What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
  • Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sexually Transmitted Disease (STD) Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Chlamydia Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Syphilis Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gonorrhea Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Herpes Simplex Virus Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Human Papilloma Virus Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Human Immunodeficiency Virus Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Chancroid Testing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Laboratory Devices
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Thermal Cyclers - PCR
      • 7.1.2.2 Lateral Flow Readers
      • 7.1.2.3 Flow Cytometers
      • 7.1.2.4 Absorbance Microplate Reader - Enzyme Linked Immunosorbent Assay (ELISA)
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Point of Care (PoC) Devices
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Phone Chips (Microfluidics + ICT)
      • 7.2.2.2 Portable/Bench Top/Rapid Diagnostic Kits
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Laboratory Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Point of Care Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 BioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid (Danaher Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Hologic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Qiagen N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Quidel Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Sexually Transmitted Disease Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Device Type (in %), 2024
  • Figure 6: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Sexually Transmitted Disease Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Sexually Transmitted Disease Diagnostics (Chlamydia Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Sexually Transmitted Disease Diagnostics (Syphilis Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Sexually Transmitted Disease Diagnostics (Gonorrhea Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Sexually Transmitted Disease Diagnostics (Herpes Simplex Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Sexually Transmitted Disease Diagnostics (Human Papilloma Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Sexually Transmitted Disease Diagnostics (Human Immunodeficiency Virus Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Sexually Transmitted Disease Diagnostics (Chancroid Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Sexually Transmitted Disease Diagnostics (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Sexually Transmitted Disease Diagnostics (Laboratory Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Sexually Transmitted Disease Diagnostics (Point of Care (PoC) Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Sexually Transmitted Disease Diagnostics (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Sexually Transmitted Disease Diagnostics (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Sexually Transmitted Disease Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Sexually Transmitted Disease Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Sexually Transmitted Disease Diagnostics Industry: Value Chain Analysis
  • Figure 83: Global: Sexually Transmitted Disease Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sexually Transmitted Disease Diagnostics Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 4: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Sexually Transmitted Disease Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Sexually Transmitted Disease Diagnostics Market: Competitive Structure
  • Table 7: Global: Sexually Transmitted Disease Diagnostics Market: Key Players